Setareh Seyedkazemi - Net Worth and Insider Trading
Setareh Seyedkazemi Net Worth
The estimated net worth of Setareh Seyedkazemi is at least $23,930 dollars as of 2024-12-27. Setareh Seyedkazemi is the Chief Development Officer of Adverum Biotechnologies Inc and owns about 4,767 shares of Adverum Biotechnologies Inc (ADVM) stock worth over $23,930. Details can be seen in Setareh Seyedkazemi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Setareh Seyedkazemi has not made any transactions after 2023-09-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Setareh Seyedkazemi
Setareh Seyedkazemi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Setareh Seyedkazemi owns 1 companies in total, including Adverum Biotechnologies Inc (ADVM) .
Click here to see the complete history of Setareh Seyedkazemi’s form 4 insider trades.
Insider Ownership Summary of Setareh Seyedkazemi
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ADVM | Adverum Biotechnologies Inc | 2023-09-15 | Chief Development Officer |
Setareh Seyedkazemi Latest Holdings Summary
Setareh Seyedkazemi currently owns a total of 1 stock. Setareh Seyedkazemi owns 4,767 shares of Adverum Biotechnologies Inc (ADVM) as of September 15, 2023, with a value of $23,930.
Latest Holdings of Setareh Seyedkazemi
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ADVM | Adverum Biotechnologies Inc | 2023-09-15 | 4,767 | 5.02 | 23,930 |
Holding Weightings of Setareh Seyedkazemi
Setareh Seyedkazemi Form 4 Trading Tracker
According to the SEC Form 4 filings, Setareh Seyedkazemi has made a total of 3 transactions in Adverum Biotechnologies Inc (ADVM) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Adverum Biotechnologies Inc is the sale of 620 shares on September 15, 2023, which brought Setareh Seyedkazemi around $9,426.
Insider Trading History of Setareh Seyedkazemi
- 1
Setareh Seyedkazemi Trading Performance
GuruFocus tracks the stock performance after each of Setareh Seyedkazemi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Setareh Seyedkazemi is 51.33%. GuruFocus also compares Setareh Seyedkazemi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Setareh Seyedkazemi within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Setareh Seyedkazemi's insider trading performs compared to the benchmark.
Performance of Setareh Seyedkazemi
Setareh Seyedkazemi Ownership Network
Setareh Seyedkazemi Owned Company Details
What does Adverum Biotechnologies Inc do?
Who are the key executives at Adverum Biotechnologies Inc?
Setareh Seyedkazemi is the Chief Development Officer of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Financial Officer Linda M Rubinstein , Chief Scientific Officer Brigit Riley , and director & CEO and Director Laurent Fischer .
Adverum Biotechnologies Inc (ADVM) Insider Trades Summary
Over the past 18 months, Setareh Seyedkazemi made 1 insider transaction in Adverum Biotechnologies Inc (ADVM) with a net sale of 6,201. Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 302,064 shares made by Braden Michael Leonard , a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , and a net purchase of 100,000 shares made by James Paul Scopa .
In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 620 shares of Adverum Biotechnologies Inc (ADVM) were sold and 325,064 shares were bought by its insiders, resulting in a net purchase of 324,444 shares.
Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adverum Biotechnologies Inc Insider Transactions
Setareh Seyedkazemi Mailing Address
Above is the net worth, insider trading, and ownership report for Setareh Seyedkazemi. You might contact Setareh Seyedkazemi via mailing address: C/o Adverum Biotechnologies, Inc., 100 Cardinal Drive, Redwood City Ca 94063.